Raloxifene 20 mg

Raloxifene 20 mg is a selective estrogen receptor modulator (SERM) primarily used in the prevention and treatment of osteoporosis in postmenopausal women. It is also prescribed to reduce the risk of invasive breast cancer in women with osteoporosis or those at elevated risk. It works by exerting estrogen-like effects on bone tissue while blocking estrogen activity in breast and uterine tissues.

How It Worksp

Raloxifene binds to estrogen receptors in different tissues, acting as an agonist in bone to help maintain or improve bone mineral density. In breast tissue, it functions as an antagonist, reducing estrogen stimulation and thereby lowering the risk of estrogen-dependent breast cancer. It also helps decrease the likelihood of vertebral fractures in postmenopausal women.

Dosage Overview

The typical dosage is 20 mg once daily, taken consistently at the same time each day, with or without food. Adherence to a regular schedule is important for maintaining stable effects. Supplementation with calcium and vitamin D may also be recommended to support bone health, depending on individual needs.

Potential Benefits

Raloxifene helps maintain bone density and reduce fracture risk in postmenopausal women. It also provides protective effects against certain types of breast cancer by blocking estrogen activity in breast tissue, offering dual benefits for bone and breast health.

Side Effects and Considerations

Common side effects include hot flashes, leg cramps, and mild swelling. More serious risks include an increased likelihood of venous thromboembolism, such as deep vein thrombosis (DVT) or pulmonary embolism. Regular medical monitoring is advised to ensure safe and appropriate use.